https://www.statnews.com/2020/08/07/the-fda-accepted-biogens-alzheimers-drug-submission-next-up-a-highly-anticipated-outside-expert-review/?utm_source=STAT+Newsletters&utm_campaign=c3f24ec2a2-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-c3f24ec2a2-149692869

The FDA accepted Biogen’s Alzheimer’s drug submission. Next up, a highly anticipated outside expert review

By ADAM FEUERSTEIN

RUBY WALLAU FOR STAT

If approved, Biogen's drug, aducanumab, would become the first medicine to slow the cognitive decline of Alzheimer’s disease.

READ MORE